BriaCell Therapeutics(NASDAQ) BCTXL

Market CapN/A

Since IPO (2026)+2%

5 YearN/A

1 YearN/A

1 Month+19%

$0.93

+8.57%

+0.07Today

BriaCell Therapeutics last closing stock price
Metric	Price	Date
Last close	USD 0.95	2026-07-27

BriaCell Therapeutics stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.95	2026-07-20
1 month	+18.75%	USD 0.80	2026-06-26
3 month	-3.06%	USD 0.98	2026-04-28
Since inception	+2.15%	USD 0.93	2026-01-14

BriaCell Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.93

Volume

Open

$0.93

Price

$0.93

Volume

Open

$0.93

Previous Close

$0.93

Daily Range

$0.93 - $0.93

52-Week Range

$0.61 - $1.40

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.93

Volume

Open

$0.93

Previous Close

$0.93

Daily Range

$0.93 - $0.93

52-Week Range

$0.61 - $1.40

Estimated Earnings Date

N/A

BCTXL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BriaCell Therapeutics

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Industry

Biotechnology

Sector

Health Care

BCTXL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

18.76K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

CurrentYOY CHG

Revenue

N/A

Gross Profit

N/A

Gross Margin

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

N/A

EBITDA

N/A

Quarterly Fundamentals

Name

CurrentYOY CHG

Total Cash

N/A

Total Debt

N/A

Accounts Receivable

N/A

Inventory

N/A

Long Term Debt

N/A

Short Term Debt

N/A

Return on Assets

N/A

Return on Invested Capital

N/A

Free Cash Flow

N/A

Operating Cash Flow

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,396.49-0.00%

^DJIDJI

^DJIDJI$52,083.00+0.00%

^IXICNASDAQ

^IXICNASDAQ$24,847.16-0.01%

BTCBitcoin

BTCBitcoin$64,796.00+0.00%

SPCXSPCX

SPCXSPCX$111.11-0.03%

AAPLAAPL

AAPLAAPL$335.09+0.01%

AMZNAMZN

AMZNAMZN$231.88-0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$91.67-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.25+0.10%

NOKNokia

NOKNokia$9.28+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.95+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.24-0.02%

TAT&T

TAT&T$24.42+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.40-0.01%

Questions About BCTXL

What is the current price of BriaCell Therapeutics?

BriaCell Therapeutics is trading at $0.93 per share.

What is the 52-week range for BriaCell Therapeutics?

Over the past 52 weeks, BriaCell Therapeutics has traded between $0.61 and $1.40.

How much debt does BriaCell Therapeutics have?

BriaCell Therapeutics total debt is unavailable.

How much cash does BriaCell Therapeutics have on hand?

BriaCell Therapeutics does not have cash on hand data available.

What is BriaCell Therapeutics’s dividend yield?

BriaCell Therapeutics does not currently have a dividend yield.

BriaCell Therapeutics(NASDAQ) BCTXL

BriaCell Therapeutics Financials at a Glance

BCTXL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BriaCell Therapeutics

BCTXL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BriaCell Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BCTXL

What is the current price of BriaCell Therapeutics?

What is the 52-week range for BriaCell Therapeutics?

How much debt does BriaCell Therapeutics have?

How much cash does BriaCell Therapeutics have on hand?

What is BriaCell Therapeutics’s dividend yield?

Premium Investing Services